|
Jerry McMahon Ph.D. was appointed chief executive officer in May 2004 chairman of the Board of Directors in June 2004 and president in June 2005. Previously he was president of SUGEN Inc. a biopharmaceutical company focused on the discovery and development of novel targeted small-molecule drugs from March 2002 to January 2004. Prior thereto he held a number of research and development management positions at SUGEN and played a key role in the discovery and development of several innovative cancer products including Sutent� a multi-targeted protein kinase inhibitor for the treatment of advanced cancers recently launched by Pfizer Inc. SUGEN which Dr. McMahon joined in 1993 was acquired by Pharmacia in 1999 which subsequently was acquired by Pfizer in 2003. Dr. McMahon currently is a director of Trellis Biosciences Inc. a development stage biotechnology company. He holds a B.S. in biology and a Ph.D. in biochemistry from Rensselaer Polytechnic Institute. | 